Another company I've invested in who are focusing on MND/ALS, also an orphan drug applicant. Are also trying to tap into the PD market, and state PD is a $9 billion US market.
From what I'm reading ATH are steps ahead with current studies, so tick off MSA $1billion US market, than grab PD add another $9billion US...I'll leave it there, and let you enjoy the mind blowing imagination of amazing SP growth, and hopeful dividends
Ann: Notice Under Section 708A, page-39
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $570 | 149.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 13513113 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130775819 | 29 |
View Market Depth
| Last trade - 15.46pm 27/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |